Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14, 181-184
- https://doi.org/10.1111/j.1469-0691.2007.01864.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical ChallengeClinical Infectious Diseases, 2006
- Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella SpeciesAntimicrobial Agents and Chemotherapy, 2006
- Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical OutcomeAntimicrobial Agents and Chemotherapy, 2006
- Bloodstream Infections Due to Extended-Spectrum β - Lactamase-Producing Escherichia coli and Klebsiella pneumoniae : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2004
- Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -LactamasesClinical Infectious Diseases, 2004
- Extended Spectrum ??-Lactamase (ESBL)-Producing EnterobacteriaceaeDrugs, 2003
- Bloodstream Infections by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical OutcomeAntimicrobial Agents and Chemotherapy, 2002
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001
- Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical CenterClinical Infectious Diseases, 1996